ConductScience.org, home

Trial · NCT01190930

Outcomes49

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYDisease Free Survival (DFS) in Average Risk (AR) Patients Based on the Methotrexate Dose Randomization5.7 yearsAverage Risk (AR) B-ALL patients who were randomized and started maintenancepercent probabilityNUMBER
PRIMARYDFS in Average Risk (AR) Patients Based on the Pulse Frequency Randomization5.7 yearsAverage Risk (AR) B-ALL patients who were randomized and started maintenancepercent probabilityNUMBER
PRIMARYDFS in Low Risk (LR) Patients Based on Randomization to 1 of 2 Low-intensity Regimens5.1 yearspercent probabilityNUMBER
PRIMARYDFS for SR Down Syndrome Patients With Standardized Treatment and Enhanced Supportive Care5.1 yearspercent probabilityNUMBER
PRIMARYSample Collection of Central Path Review Slides in B-LLy PatientsUp to 1 monthpatients who had samples collected near diagnosispercentage of patientsNUMBER
PRIMARYEvent Free Survival (EFS) for B-LLy Patients5 yearsIneligible patients are excludedpercent probabilityNUMBER
PRIMARYOverall Survival (OS) for B-LLy Patients5 yearsIneligible patients are excludedpercent probabilityNUMBER
SECONDARYBurden of Therapy in AR Patients Overall at End of Consolidation Therapy: Emotional2 MonthsAR patients who had data collectedZ-ScoreMEAN
SECONDARYBurden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: Emotional1 yearAR patients who had data collectedZ-ScoreMEAN
SECONDARYBurden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: Emotional1.7 yearsAR patients who had data collectedZ-ScoreMEAN
SECONDARYBurden of Therapy in AR Patients Overall at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Emotional2.5 yearsAR patients who had data collectedZ-ScoreMEAN
SECONDARYBurden of Therapy in Boy AR Patients Overall at End of Therapy: Emotional3.2 yearsAR boy patients who had data collectedZ-ScoreMEAN
SECONDARYBurden of Therapy in AR Patients Overall at End of Consolidation Therapy: Physical2 MonthsAR patients who had data collectedZ-ScoreMEAN
SECONDARYBurden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: Physical1 YearAR patients who had data collectedZ-ScoreMEAN
SECONDARYBurden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: Physical1.7 yearsAR patients who had data collectedZ-ScoreMEAN
SECONDARYBurden of Therapy in AR Patients Overall at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Physical2.4 YearsAR patients who had data collectedZ-ScoreMEAN
SECONDARYBurden of Therapy in Boy AR Patients Overall at End of Therapy: Physical3.2 yearsAR boy patients who had data collectedZ-ScoreMEAN
SECONDARYBurden of Therapy in AR Patients Overall at End of Consolidation Therapy: School2 MonthsData are unavailable
SECONDARYBurden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: School1 YearData are unavailable
SECONDARYBurden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: School1.7 YearsData are unavailable

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01190930/outcomes